ZO Skin Health: A Physician's Guide to the Programme

ZO Skin Health was developed by Dr Zein Obagi, a dermatologist with more than four decades of clinical practice who became dissatisfied with what he saw as the gap between the rigorous science of dermatology and the relatively unscientific products available to patients. The result was a prescription-grade skincare system designed not for passive maintenance, but for active skin health optimisation.

At London & Glow, we offer ZO Skin Health as part of our broader commitment to physician-led skin care — and specifically as a programme that can support and extend the results of in-clinic treatments for our patients navigating menopausal skin change.

The ZO Philosophy: Treating the Biology, Not Just the Surface

Most skincare products are designed around patient acceptability: they should feel pleasant, not cause redness, and show some cosmetic improvement quickly. ZO Skin Health is designed around a different principle: what does the skin biology actually need, and how do we provide it at therapeutic concentrations?

The implications of this are significant. Some ZO products cause an initial adaptation period — a period of increased skin turnover that can manifest as mild dryness, flakiness, or sensitivity before the skin adjusts and improves. This is not a sign of damage; it is a sign that the products are working at a level that creates genuine change.

This is one of the reasons ZO Skin Health should be supervised by a physician or experienced clinician. Starting the wrong products in the wrong order, or using products at concentrations or frequencies inappropriate for a particular skin type, can cause unnecessary disruption.

Key Active Ingredients and Their Roles

Retinol and retinoids are central to the ZO system. Retinol is a vitamin A derivative that accelerates cellular turnover, stimulates collagen synthesis, and helps normalise the dysregulation in sebaceous gland activity that oestrogen decline produces. The evidence base for retinoids in skin ageing is among the most robust in dermatology — no other topical ingredient has comparable peer-reviewed support for reversing visible ageing.

For menopausal skin, retinoids are particularly valuable because they address two of the key consequences of oestrogen deficiency simultaneously: they stimulate fibroblast activity (supporting collagen production) and they accelerate epidermal turnover (improving texture and radiance).

Niacinamide (vitamin B3) is used across several ZO formulations for its ability to support barrier function, reduce trans-epidermal water loss, and modulate pigmentation. Menopausal skin typically shows increased barrier disruption — niacinamide supports the restoration of this barrier.

Antioxidants — including vitamin C, vitamin E, and various plant-derived compounds — address the oxidative stress component of skin ageing. Reactive oxygen species accelerate collagen degradation; antioxidants neutralise this damage.

Exfoliating agents in the ZO system include alpha hydroxy acids (glycolic, lactic) and beta hydroxy acids (salicylic), which improve cellular turnover and surface texture without stripping the skin of essential lipids.

How the Programme Is Structured

ZO Skin Health is not a one-size-fits-all system. The programme for each patient is tailored to their specific skin concerns, current condition, and treatment goals.

A typical programme might include:

• A daily cleanser appropriate for skin type
• An exfoliating preparation (the Exfoliating Polish or Renewal Creme)
• Targeted actives (vitamin C, retinol, brightening agents)
• SPF during the day — essential, particularly when using retinoids

We begin with a skin consultation that includes an assessment of current products, skin concerns, and any relevant medical history. We then recommend a starting regimen — often simpler than patients expect — and build from there as the skin adapts.

ZO in the Context of In-Clinic Treatments

ZO Skin Health works best when combined with clinic-based treatments. The logic is straightforward: in-clinic treatments (microneedling, polynucleotides, skin boosters) create opportunities for regeneration; ZO products provide the cellular signals and nutritional support to maximise the benefit of those treatments.

For example, a patient who has completed a course of microneedling and begins a ZO programme with an appropriate retinol will produce more collagen than either treatment alone — the microneedling creates the stimulus, and the retinoid enhances the fibroblast response.

This is not theoretical. Several clinical studies have examined the combination of microneedling with topical retinoids and found greater improvements in collagen density and surface texture than with either treatment alone.

Why Physician Supervision Matters

Physician-grade skincare products are not inherently safer than consumer products — in some cases, they are more potent, and therefore require more careful use. The risks of using high-concentration retinoids incorrectly — including a compromised barrier, reactive skin, and post-inflammatory hyperpigmentation — are real.

At London & Glow, we do not sell ZO products as retail items to be used at the patient's discretion. We prescribe them as part of a supervised programme, with follow-up to assess the skin's response and adjust the regimen accordingly. This is what physician-led skincare means in practice.